Before you watch this webinar

Enhancing your learning experience begins with understanding you better. Collecting data enables us to tailor our educational content specifically for our audience. Discover more about how we handle your information in our Privacy Policy.

Marketing Preferences

Event

Implementing the 2024 MS diagnostic criteria: what earlier detection means for UK services


22 Jun 2026 17:15 - 18:15

Our sponsor
Juvise logo

This activity has been financially supported by sponsorship from Juvisé Pharmaceuticals. The sponsor has had no control over the educational content or organisation of this activity.

Please note that all session and slide content are the views of the speakers, not the Neurology Academy. The content of the recording is the speaker’s personal opinion at the time of recording. Due to the everchanging situation, advice given at the time of recording is subject to change
Overview

The 2024 revisions to the McDonald diagnostic criteria are enabling earlier and more confident MS diagnoses — but they also bring significant implications for UK MS services. Earlier identification is likely to increase demand across neurology, radiology and treatment pathways, requiring centres to adapt quickly, safely and sustainably.

This webinar focuses on the practical realities of implementing the updated criteria. We will explore how services can redesign diagnostic pathways, manage rising capacity pressures, and make evidence based treatment decisions for individuals diagnosed earlier or with minimal symptoms. The session will also address how to communicate diagnostic uncertainty in a way that supports patient understanding and shared decision making.

Designed for MS clinicians, nurses, AHPs and service managers, this session will help you understand what these changes mean for day to day practice — and how your service can respond effectively.

Objectives
  • Implement the updated 2024 MS diagnostic criteria within your centre, including practical steps, governance considerations and common pitfalls
  • Anticipate and manage increased demand on neurology, radiology and treatment pathways resulting from earlier and expanded diagnosis
  • Apply structured, evidence based approaches to treatment decision making for individuals diagnosed earlier or with minimal symptoms
  • Use effective communication strategies to explore diagnostic uncertainty with patients in a clear, compassionate and comprehensible way
Presentation slides

Our sponsor
Juvise logo

This activity has been financially supported by sponsorship from Juvisé Pharmaceuticals. The sponsor has had no control over the educational content or organisation of this activity.

CPD accreditation

We will apply for CPD accreditation from the Royal College of Physicians for this webinar.

Encouraging excellence, developing leaders, inspiring change

MS Academy was established in 2016 and in that time has accomplished a huge amount with exciting feedback demonstrating delegates feel inspired and energised along their personal and service development journeys. The various different levels of specialist MS training we offer are dedicated to case-based learning and practical application of cutting edge research.